In recent years, the biotech sector has faced significant challenges in the initial public offering (IPO) market. The economic downturn and financial uncertainties have created a tough environment for companies looking to go public. However, some biotech firms, such as Bicara Therapeutics and Zenas
The biopharmaceutical industry is in a state of flux, marked by the FDA's scrutiny of immunotherapy drugs, financial challenges faced by biotech startups, and promising advancements in vaccine development and obesity treatments. As regulatory, operational, and market dynamics evolve, companies must
The transformative journey of eXmoor Pharma has reached a pivotal moment with the recent acquisition of a Manufacturing and Import Authorization for Investigational Medicinal Products (MIA(IMP)) license from the UK's Medicines and Healthcare products Regulatory Agency (MHRA). This milestone
The journey of developing groundbreaking cancer therapies is fraught with challenges and triumphs, and the clinical trial of BNT326/YL202 by BioNTech and MediLink Therapeutics is no exception. This antibody-drug conjugate (ADC) candidate has shown promise in treating non-small cell lung cancer and
Sustainability has become a paramount concern in the biopharma industry, as evidenced by a recent comprehensive survey conducted by Cytiva and the Financial Times research unit, FT Longitude. This survey, involving over 800 executives from diverse global companies, reveals a growing commitment to
Employee turnover in the biopharma industry has reached unprecedented levels in recent years, causing a significant threat to intellectual property (IP) security. As the sector grapples with layoffs and recruitment shifts, there is an increasing need to understand how these workforce changes impact
Regeneron Pharmaceuticals recently hit a roadblock in its quest to bring its experimental multiple myeloma drug, linvoseltamab, to market. Although the drug promises significant benefits to patients, manufacturing flaws at a third-party facility have delayed FDA approval. This analysis delves into
Recent tensions between the United States and China have extended into the biotech and pharmaceutical sectors, sparking bipartisan calls for increased regulatory scrutiny. At the heart of the matter: clinical trials conducted by U.S. pharmaceutical companies in collaboration with Chinese
The second quarter of 2024 marked a significant period for the top 20 biopharmaceutical companies as they navigated improving global markets. Bolstered by investor optimism and anticipated interest rate cuts from the US Federal Reserve, these companies showed robust performances and strategic
Fujifilm Diosynth Biotechnologies has taken a significant step toward bolstering its microbial production capabilities with the inauguration of a new microbial fermentation manufacturing facility in Billingham, UK. As a leading contract development and manufacturing organization (CDMO), the company
